People

MAP Pharmaceuticals has hired Frederick H. Graff as VP, Commercial Operations, a position newly created in anticipation of a potential launch of the company's Levadex inhaled dihydroergotamine (DHE) for the treatment of migraine. Graff was previously Senior VP of Sales at Sepracor, where he led the launch of Xopenex levalbuterol inhalation solution. The announcement … [Read more...] about MAP hires Frederick Graff to lead launch of inhaled migraine drug

Jim Nightingale has been promoted from Senior VP for Business Development and Strategic Alliances to President of drug development company Bend Research. Rod Ray is stepping down as President but will remain as CEO and chairman of the board. David Lyon, current VP of Research will assume the Business Development responsibilities. Until two years ago, Bend … [Read more...] about Bend Research names Nightingale as president

Inhaled antibiotic developer Insmed has hired Andrea ("Andi") Holtzman Drucker as its Senior Vice President, General Counsel and Corporate Secretary, which is a newly-created position reporting directly to Insmed President and CEO Timothy Whitten. Drucker commented, "I am excited to be joining the Insmed management team, and look forward to working with the Company as … [Read more...] about Insmed hires new General Counsel

Pulmatrix, which recently launched its new iSperse dry powder delivery system, has announced the promotion of Robert Clarke to Chief Scientific Officer (CSO) and VP of Research and Development. In addition, the company has added 8 members to its scientific advisory board. Clarke has been leading research efforts at Pulmatrix since 2004 after leaving Alkermes. … [Read more...] about Pulmatrix announces new appointments

Canadian biotech company Asmacure has announced that Martin Driscoll will replace Luc Vachon as Chief Executive Officer. Vachon is leaving the company "to pursue other business ventures." Asmacure is developing an inhaled nictonic receptor agonist, ASM-024, as a treatment for asthma. Driscoll worked most recently as CEO of Javelin Pharmaceuticals, which merged … [Read more...] about Asmacure announces new CEO

Activaero has hired Christian Pangratz as its new Chief Business Officer, replacing Henrik Luessen. Pangratz comes to Activaero from Nektar, where he served as Executive Director of Business Development. Luessen will continue to work with the company part time while focusing the majority of his efforts on his consulting firm. Pangratz will be responsible for … [Read more...] about Activaero announces new Chief Business Officer

Chuck Bramlage has been appointed President and Chief Executive Officer of Pearl Therapeutics, replacing interim President and CEO Howard Rosen. Pearl, a California pharmaceutical company developing inhaled treatments for COPD and asthma, was founded in 2006. Its lead product, PT 003, a LAMA/LABA combination MDI, is moving into Phase 2b trials. Bramlage was most … [Read more...] about Pearl Therapeutics announces new President and CEO

Scott R. Ward has been named Chairman of the Board of Directors by MAP Pharmaceuticals, replacing Staven A. Elms. MAP plans to submit an NDA for its Levadex inhaled ergotamine for the treatment of migraine headaches within the next few months. Read the company's press release. … [Read more...] about MAP Pharmaceuticals appoints new board chair

CMO PharmaForm, a wholly-owned subsidiary of Akela Pharma, has hired J. Blair West, formerly of Bend Research and Azo Pharma, as Vice President of Pharmaceutical Operations. In addition, the company says, Feng Zhang will become Senior Formulation Consultant. PharmaForm provides formulation and manufacturing services for a number of dosage forms, including dry … [Read more...] about PharmaForm announces new hires